Engage Workshops: Upload your Science to the Cloud
A special edition of GSAS Harvard Biotech Club and Benchling.
Workshop Overview
Do you want to learn how to use digital tools to accelerate innovation at biotech startups? Join Drake Garner, PhD and Aaron Steger, Benchling’s academic evangelist and startup lead for a discussion about emerging startups trends. Then learn to use Benchling to build an investor pitch.
Description and Structure
This course, designed in collaboration with Benchling, aims to educate academic trainees about the current trends and strategies within the biotech startup ecosystem.
During the first session of the course, students will hear about example startups and gain insights into what made them successful. Then students will learn how to centralize and organize their science by working through an example Investor Pitch completely within Benchling.
Before the second session, students will form groups and design their own investor pitch within Benchling. Working collaboratively on Benchling the students will virtually design a CRISPR edited organism and compile their findings in the form of an investor pitch. In the second session, a panel of investors will choose the group with the best pitch!
Workshop Expectations
During this virtual workshop, participants can expect to gain insights into sharing and organizing data, working virtually with collaborators, designing plasmids, running batch CRISPR experiments, creating sequence alignments, analyzing NT and AA files, and more all within the Benchling product.
Attendance is not required for both sessions, but strongly encouraged.
To be eligible to win “Best Pitch” you must attend both sessions.
Expect to commit ~10 hours when building your investor pitch!
Dates:
Session 1: April 20th, 3-5PM EST
Session 2: May 4th, 3-5PM EST
Zoom link will be provided upon acceptance
Benchling
Benchling’s mission is to unlock the power of biotechnology. Come join over 200,000 scientists using Benchling to power life science R&D! At its core, Benchling is a virtual lab notebook combined with a suite of molecular tools making documenting and visualizing scientific data easy. Between 2020-21 over 1 in 4 biotech IPOs came from companies running R&D on Benchling
Benchling is always FREE to academics.
Please RSVP HERE